Publications 2020

Research articles

  1. Thomas, R., Michaleff, Z., Greenwood, H., Abukmail, E. and Glasziou, P., 2020. Concerns and misconceptions about the Australian Government's COVIDSafe App: A cross-sectional online survey. JMIR public health and surveillance, doi: 10.2196/23081. Online ahead of print..
  2. Bryant, E.A., Scott, A.M. and Thomas, R., 2020. Patient and public involvement in the development of clinical practice guidelines: a scoping review protocol. BMJ open, 10(10), p.e037327.
  3. Bakhit, M., Hoffmann, T., Santer, M., Ridd, M., Francis, N., Hummers, E., Clark, J., Hilliges, C. and Del Mar, C., 2020. Comparing the quantity and quality of randomised placebo-controlled trials of antibiotics for acute respiratory, urinary, and skin and soft tissue infections: a scoping review. BJGP open.
  4. Frank, O., Stocks, N. and Del Mar, C., 2020. Does point-of-care testing in general practice for leucocyte and differential count change use of antimicrobial medicines? A pilot study. Australian Journal of Primary Health.
  5. Cardona, M., Dobler, C.C., Koreshe, E., Heyland, D.K., Nguyen, R., Sim, J.P., Clark, J. and Psirides, A., 2020. Supporting decision-making on allocation of ICU beds and ventilators in pandemics.
  6. Scandurra, G., Degeling, C., Douglas, P., Dobler, C.C. and Marais, B., 2020. Tuberculosis in migrants–screening, surveillance and ethics. Pneumonia, 12(1), pp.1-8.
  7. Napieralska, M., Pawłowska, I. and Krzyzaniak, N., 2020. Neonatal abstinence syndrome in a newborn delivered by an opioid-dependent mother using methadone substitution therapy during pregnancy. Palliative Medicine in Practice, 14(2), pp.124-126.
  8. Jolliffe, L., Hoffmann, T., Laver, K., McCluskey, A. and Lannin, N.A., 2020. Stroke rehabilitation research translation in Australia: a survey of clinical trialists. Disability and Rehabilitation, pp.1-7.
  9. Albarqouni, L., Byambasuren, O., Clark, J., Scott, A.M., Looke, D. and Glasziou, P., 2020. Does Copper treating of commonly touched surfaces reduce healthcare acquired infections? A Systematic Review and meta-analysis. Journal of Hospital Infection.
  10. Cardona, M., Anstey, M., Lewis, E.T., Shanmugan, S., Hillman, K. and Psirides, A., 2020. Appropriateness of intensive care treatments near the end of life during the COVID-19 pandemic. Breathe, 16(2): 200062.
  11. Hoffmann, T.C., Del Mar, C., Santhirapala, R. and Freeman, A., 2020. Teaching clinicians shared decision making and risk communication online: an evaluation study. BMJ Evidence-Based Medicine.
  12. Hoffmann, T., Peiris, R., Del Mar, C., Cleo, G. and Glasziou, P., 2020. Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review. British Journal of General Practice.
  13. Howick, J., Webster, R.K., Rees, J.L., ...., Hoffmann, T., 2020. TIDieR-Placebo: A guide and checklist for reporting placebo and sham controls. PLoS medicine, 17(9), p.e1003294.
  14. Sharma, S., Traeger, A.C., O’Keeffe, M., Copp, T., Freeman, A., Hoffmann, T. and Maher, C.G., 2020. Effect of information format on intention and beliefs regarding diagnostic imaging for non-specific low back pain: A randomised controlled trial in members of the public. Patient Education and Counseling.
  15. Sharma, S., Traeger, A.C., Reed, B., Hamilton, M., O’Connor, D.A., Hoffmann, T.C., Bonner, C., Buchbinder, R. and Maher, C.G., 2020. Clinician and patient beliefs about diagnostic imaging for low back pain: a systematic qualitative evidence synthesis. BMJ open, 10(8), p.e037820.
  16. Ranakusuma, R.W., McCullough, A.R., Safitri, E.D., Pitoyo, Y., Widyaningsih, W., Del Mar, C.B., and Beller, E.M. 2020. Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study). Pilot Feasibility Stud, 6(1)121.
  17. Ooi, M., Lewis, E.T., Brisbane, J., Tubb, E., McClean, T., Assareh, H., Hillman, K., Achat, H. and Cardona, M., 2020, September. Feasibility of Using a Risk Assessment Tool to Predict Hospital Transfers or Death for Older People in Australian Residential Aged Care. A Retrospective Cohort Study. Healthcare, 8(3), p. 284. Multidisciplinary Digital Publishing Institute.
  18. Pokorny, A.M., Bero, L.A., Moynihan, R. and Mintzes, B.J., 2020. Industry payments to Australian medical oncologists and clinical haematologists: a cross‐sectional analysis of publicly‐available disclosures. Internal Medicine Journal.
  19. Muscat, D.M., Patel, P., Reid, S., Hoffmann, T., Albarqouni, L. and Trevena, L., 2020. Content analysis of clinical questions from Australian general practice which are prioritised for answering: identifying common question types and perceived knowledge gaps. BMJ Evidence-Based Medicine, 25(1), pp.15-21.
  20. Byambasuren, O., Beller, E., Hoffmann, T. and Glasziou, P., 2020. Barriers to and Facilitators of the Prescription of mHealth Apps in Australian General Practice: Qualitative Study. JMIR mHealth and uHealth, 8(7), p.e17447.
  21. Blom, J.W., Muth, C., Glasziou, P., McCormack, J., Perera, R., Poortvliet, R.K.E., Numans, M.E., Thürmann, P., Thiem, U., Thio, S.L. and Van Driel, M., 2020. Describing deprescribing trials better: an elaboration of the CONSORT statement. Journal of Clinical Epidemiology.
  22. Dobler, C.C., Hakim, M., Singh, S., Jennings, M., Waterer, G. and Garden, F.L., 2020. Ability of the LACE index to predict 30-day hospital readmissions in patients with community-acquired pneumonia. ERJ Open Research, 6(2).
  23. McDonald, C.F., Jones, S., Beckert, L., Bonevski, B., Buchanan, T., Bozier, J., Carson‐Chahhoud, K.V., Chapman, D.G., Dobler, C.C., Foster, J.M. and Hamor, P., 2020. Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand. Respirology.
  24. Nickel, B., Moynihan, R., Barratt, A., Brito, J.P. and McCaffery, K., 2020. Media coverage of calls to rename low-risk cancers: a content analysis. BMJ open, 10(7), p.e038087.
  25. Moher, D., Bouter, L., Kleinert, S., Glasziou, P., Sham, M.H., Barbour, V., Coriat, A.M., Foeger, N. and Dirnagl, U., 2020. The Hong Kong Principles for assessing researchers: Fostering research integrity. PLoS Biology, 18(7), p.e3000737.
  26. Freak-Poli, R.L., Cumpston, M., Albarqouni, L., Clemes, S.A. and Peeters, A., 2020. Workplace pedometer interventions for increasing physical activity. Cochrane Database of Systematic Reviews, Issue 7. Art. No.: CD009209
  27. Barratt Ross, S., Kumar, M., Dillon, A., Bahudin, D. and Cardona, M., 2020. COVID-19 impact on medical education and the future post-pandemic era for medical students. The British Student Doctor Journal, 4(2), 54-59.
  28. Lee, X.J., Farrington, A., Carter, H., Shield, C., Graves, N., McPhail, S.M., Harvey, G., White, B.P., Willmott, L., Cardona, M. and Hillman, K., 2020. A stepped-wedge randomised-controlled trial assessing the implementation, impact and costs of a prospective feedback loop to promote appropriate care and treatment for older patients in acute hospitals at the end of life: study protocol. BMC Geriatrics, 20(1), pp.1-9.
  29. Gonzalez-Gonzalez, A.I., Schmucker, C., Nothacker, J., Nguyen, T.S., Brueckle, M.S., Blom, J., van den Akker, M., Röttger, K., Wegwarth, O., Hoffmann, T. and Gerlach, F.M., 2020. End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review. BMJ open, 10(7), p.e038682.
  30. Rozbroj, T., Haas, R., O’Connor, D.A., Thomas, R., McCaffery, K., Carter, S. and Buchbinder, R., 2020. How do patients and the public understand overtesting and overdiagnosis? A protocol for a thematic meta-synthesis of qualitative research. BMJ Open, 10(7), p.e037283.
  31. Ho, C.L., Breslin, M., Chowdhury, E.K., Doust, J., Reid, C.M., Davis, B.R., Simpson, L.M. and Nelson, M.R., 2020. Lack of a significant legacy effect of baseline blood pressure ‘treatment naivety’on all-cause and cardiovascular mortality in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Journal of Hypertension, 38(3), pp.519-526.
  32. Lewis, E.T., Harrison, R., Nicholson, M., Hillman, K., Trankle, S., Rangel, S., Stokes, C. and Cardona, M., 2020. Clinicians’ and public acceptability of universal risk‑of‑death screening for older people in routine clinical practice in Australia: cross‑sectional surveys. Aging Clinical and Experimental Research.
  33. Gurgel-Juarez, N., Perrier, M.F., Hoffmann, T., Lannin, N., Jolliffe, L., Lee, R., Brosseau, L. and Flowers, H., 2020. Guideline Recommendations for Oral Care After Acquired Brain Injury: Protocol for a Systematic Review. JMIR Research Protocols9(7), p.e17249.
  34. Abdalhadi, A., Al-khatib, M., Mismar, A.Y., Awouda, W. and Albarqouni, L., 2020. Can COVID 19 Present like appendicitis?. IDCases, p.e00860.
  35. Dobler, C.C., Morrow, A.S., Farah, M.H., Beuschel, B., Majzoub, A.M., Wilson, M.E., Hasan, B., Seisa, M.O., Daraz, L., Prokop, L.J. and Murad, M.H., 2020, June. Nonpharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-Analysis. In Mayo Clinic Proceedings (Vol. 95, No. 6, pp. 1169-1183). Elsevier.
  36. Byambasuren, O., Beller, E., Hoffmann, T. and Glasziou, P., 2020. mHealth App Prescription in Australian General Practice: Pre-Post Study. JMIR mHealth and uHealth, 8(6), p.e16497.
  37. Olsen, M., Campos, M., Lohning, A., Jones, P., Legget, J., Bannach-Brown, A., McKirdy, S., Alghafri, R. and Tajouri, L., 2020. Mobile phones represent a pathway for microbial transmission: A scoping review. Travel Medicine and Infectious Disease, p.101704.
  38. Downie, A.S., Hancock, M., Shaheed, C.A., McLachlan, A.J., Kocaballi, A.B., Williams, C.M., Michaleff, Z.A. and Maher, C.G., 2020. An Electronic Clinical Decision Support System for the Management of Low Back Pain in Community Pharmacy: Development and Mixed Methods Feasibility Study. JMIR medical informatics, 8(5), p.e17203.
  39. Jolliffe, L., Hoffmann, T., Churilov, L. and Lannin, N.A., 2020. What is the feasibility and observed effect of two implementation packages for stroke rehabilitation therapists implementing upper limb guidelines? A cluster controlled feasibility study. BMJ Open Quality, 9(2), p.e000954.
  40. Moynihan, R., Albarqouni, L., Nangla, C., Dunn, A.G., Lexchin, J. and Bero, L. 2020. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ, 369:m1505
  41. Moynihan, R., Fabbri, A., Parker, L. and Bero, L., 2020. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ open, 10(5), p.e034195.
  42. Byambasuren, O., Cardona, M., Bell, K., Clark, J., McLaws, M.L. and Glasziou, P., 2020. Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. medRxiv.
  43. Braithwaite, J., Glasziou, P. and Westbrook, J., 2020. The three numbers you need to know about healthcare: the 60-30-10 Challenge. BMC medicine, 18(1), pp.1-8.
  44. Hoffmann, T.C., Lewis, J. and Maher, C.G., 2020. Shared decision making should be an integral part of physiotherapy practice. Physiotherapy, 107, pp.43-49.
  45. Kelly, J.T., Conley, M., Hoffmann, T., Craig, J.C., Tong, A., Reidlinger, D.P., Reeves, M.M., Howard, K., Krishnasamy, R., Kurtkoti, J. and Palmer, S.C., 2020. A Coaching Program to Improve Dietary Intake of Patients with CKD: ENTICE-CKD. Clinical Journal of the American Society of Nephrology, 15(3), pp.330-340.
  46. Holloway, K.A., Ivanovska, V., Manikandan, S., Jayanthi, M., Mohan, A., Forte, G. and Henry, D., 2020. Identifying the most effective essential medicines policies for quality use of medicines: A replicability study using three World Health Organisation data-sets. Plos one, 15(2), p.e0228201.
  47. de Cassan, S., Thompson, M.J., Perera, R., Glasziou, P.P., Del Mar, C.B., Heneghan, C.J. and Hayward, G., 2020. Corticosteroids as standalone or add‐on treatment for sore throat. Cochrane Database of Systematic Reviews,  Issue 5. Art. No.: CD008268.
  48. Sender, D., Clark, J. and Hoffmann, T., 2020. Analysis of articles directly related to randomised trials finds poor protocol availability and inconsistent linking of articles. Journal of Clinical Epidemiology.
  49. Doshi, P., Bourgeois, F., Hong, K., Jones, M., Lee, H., Shamseer, L. and Jefferson, T., 2020. Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology. BMJ Evidence-Based Medicine.
  50. Lewis, E.T., Mahimbo, A., Linhart, C., Williamson, M., Morgan, M., Hammill, K., Hall, J. and Cardona, M., 2020. General practitioners’ perceptions on the feasibility and acceptability of implementing a risk prediction checklist to support their end-of-life discussions in routine care: a qualitative study. Family Practice, cmaa036.
  51. Clark, J.M., Sanders, S., Carter, M., Honeyman, D., Cleo, G., Auld, Y., Booth, D., Condron, P., Dalais, C., Bateup, S. and Linthwaite, B., 2020. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. Journal of the Medical Library Association: JMLA, 108(2), p.195.
  52. Grande, A.J., Keogh, J., Silva, V. and Scott, A.M., 2020. Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections. Cochrane Database of Systematic Reviews, Issue 4, Art. No.: CD010596.
  53. Glasziou, P.P., Jones, M.A., Pathirana, T., Barratt, A.L., Bell, K.J., 2019. Estimating the magnitude of cancer overdiagnosis in Australia. MJA, 212(4):163-168. Erratum: MJA 212(6): 253.
  54. Albarqouni, L., Glasziou, P., Bakhit, M., Del Mar, C. and Hoffmann, T.C., 2020. Development of a contemporary evidence-based practice workshop for health professionals with a focus on pre-appraised evidence and shared decision-making: a before-after pilot study. BMJ Evidence-Based Medicine, 25(2), pp.1-2.
  55. Copp, T., Muscat, D.M., Hersch, J., McCaffery, K.J., Doust, J., Mol, B.W., Dokras, A. and Jansen, J., 2020. Clinicians’ perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study. Human Reproduction, 35(3), pp.660-668.
  56. Brueckle, M.S., Thomas, E.T., Seide, S.E., Pilz, M., Gonzalez-Gonzalez, A.I., Nguyen, T.S., Harder, S., Glasziou, P.P., Gerlach, F.M. and Muth, C., 2020. Adverse drug reactions associated with amitriptyline—protocol for a systematic multiple-indication review and meta-analysis. Systematic Reviews, 9(1), pp.1-8.
  57. Cipriani, A., Ioannidis, J.P., Rothwell, P.M., Glasziou, P., Li, T., Hernandez, A.F., Tomlinson, A., Simes, J. and Naci, H., 2020. Generating comparative evidence on new drugs and devices after approval. The Lancet, 395(10228), pp.998-1010.
  58. Clark, J., Glasziou, P., Del Mar, C., Bannach-Brown, A., Stehlik, P. and Scott, A.M., 2020. A full systematic review was completed in 2 weeks using automation tools: a case study. Journal of Clinical Epidemiology, 121, pp.81-90.
  59. Cao, S., Jones, M., Tooth, L. and Mishra, G.D., 2020. History of premenstrual syndrome and development of postpartum depression: A systematic review and meta-analysis, Journal of Psychiatric Research, vol. 121, pp. 82-90.
  60. Wilson, M.E., Mittal, A., Karki, B., Dobler, C.C., Wahab, A., Curtis, J.R., Erwin, P.J., Majzoub, A.M., Montori, V.M., Gajic, O. and Murad, M.H., 2020. Do-not-intubate orders in patients with acute respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine, 46(1), pp.36-45.
  61. Ho, C.L., Sanders, S., Breslin, M., Doust, J., Reid, C.M., Davis, B.R., Simpson, L.M., Brouwers, F.P. and Nelson, M.R., 2020. Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis. Journal of Human Hypertension, pp.1-10.
  62. Stehlik, P., Noble, C., Brandenburg, C., Fawzy, P., Narouz, I., Henry, D. and Glasziou, P., 2020. How do trainee doctors learn about research? Content analysis of Australian specialist colleges’ intended research curricula. BMJ open, 10(3), p.e034962.
  63. Bach, A.C., Lo, K.S., Pathirana, T., Glasziou, P.P., Barratt, A.L., Jones, M.A. and Bell, K.J., 2020. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk. MJA, 212(1), pp.17-22.
  64. Platt, R.W., Platt, R., Brown, J.S., Henry, D.A., Klungel, O.H. and Suissa, S., 2020. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiology and drug safety, 29, pp.3-7.
  65. Trankle, S.A., Shanmugam, S., Lewis, E., Nicholson, M., Hillman, K. and Cardona, M., 2020. Are we making progress on communication with people who are near the end of life in the Australian Health System? A thematic analysis. Health communication, 35(2), pp.158-167.
  66. Copp, T., Cvejic, E., McCaffery, K., Hersch, J., Doust, J., Mol, B.W., Dokras, A., Mishra, G. and Jansen, J., 2020. Impact of a diagnosis of polycystic ovary syndrome on diet, physical activity and contraceptive use in young women: findings from the Australian Longitudinal Study of Women’s Health. Human Reproduction, 35(2), pp.394-403.
  67. White, H., Venkatesh, B., Jones, M., Kruger, P.S., Walsham, J. and Fuentes, H., 2020. Inducing ketogenesis via an enteral formulation in patients with acute brain injury: a phase II study. Neurological Research, pp.1-11.
  68. Hoschar, S., Albarqouni, L. and Ladwig, K.H., 2020. A systematic review of educational interventions aiming to reduce prehospital delay in patients with acute coronary syndrome. Open Heart, 7(1), p.e001175.
  69. Smith, L., Barratt, A., Buchbinder, R., Harris, I.A., Doust, J. and Bell, K., 2020. Trends in knee magnetic resonance imaging, arthroscopies and joint replacements in older Australians: still too much low‐value care?. ANZ journal of surgery.
  70. Schünemann, H.J., Mustafa, R.A., Brozek, J., Steingart, K.R., Leeflang, M., Murad, M.H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S. and Meerpohl, J., 2020. GRADE guidelines: 21 part 2. Inconsistency, Imprecision, publication bias and other domains for rating the certainty of evidence for test accuracy and presenting it in evidence profiles and summary of findings tables. Journal of clinical epidemiology In press).
  71. Schünemann, H.J., Mustafa, R.A., Brozek, J., Steingart, K.R., Leeflang, M., Murad, M.H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S. and Meerpohl, J., 2020. GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy. Journal of clinical epidemiology (in press)
  72. Thomas, R., Scott, A.M., Sims, R., Craig, L., Claase, L.A., Lowe, J., Heal, C., Hardiman, L. and Glasziou, P., 2020. Exploring women’s priorities for the potential consequences of a gestational diabetes diagnosis: A pilot community jury. Health Expectations.
  73. Dobler, C.C., Morrow, A.S., Beuschel, B., Farah, M.H., Majzoub, A.M., Wilson, M.E., Hasan, B., Seisa, M.O., Daraz, L., Prokop, L.J. and Murad, M.H., 2020. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis. Ann Intern Med.
  74. Fabbri, A., O'Keeffe, M., Moynihan, R., Møllebæk, M., Mohammad, A., Bhasale, A., Puil, L. and Mintzes, B., 2020. Media coverage of drug regulatory agencies’ safety advisories: a case study of citalopram and denosumab. British Journal of Clinical Pharmacology.
  75. Dummer, J., Dobler, C.C., Holmes, M., Chambers, D., Yang, I.A., Parkin, L., Smith, S., Wark, P., Dev, A., Hodge, S. and Dabscheck, E., Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand. Respirology.
  76. Scott, I.A., Attia, J. and Moynihan, R., 2020. Promises and perils of using genetic tests to predict risk of disease. BMJ, 368, m18.
  77. Arab-Zozani, M., Moynihan, R.N. and Pezeshki, M.Z., 2020. Shared decision making: How can it be helpful in reducing medical overuse due to medical misinformation mess?. Journal of evaluation in clinical practice.
  78. Craig, L., Sims, R., Glasziou, P. and Thomas, R., 2020. Women’s experiences of a diagnosis of gestational diabetes mellitus: a systematic review. BMC Pregnancy and Childbirth, 20(1), p.76.
  79. Gardner, H.R., Albarquoni, L., El Feky, A., Gillies, K. and Treweek, S., 2020. A systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials. F1000Research, 9(86), p.86.
  80. Scott, A.M., Clark, J., Del Mar, C. and Glasziou, P., 2020. Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis. British Journal of General Practice, 70(692):E200-E207.
  81. Scott, A.M., Kolstoe, S., Ploem, M.C., Hammatt, Z. and Glasziou, P., 2020. Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands. Health Research Policy and Systems, 18(1), pp.1-8.
  82. Platt, R.W., Henry, D.A. and Suissa, S., 2020. The Canadian Network for Observational Drug Effect Studies (CNODES): Reflections on the first eight years, and a look to the future. Pharmacoepidemiology and Drug Safety, 29(51): 103-107.
  83. Zhou, Z., Albarqouni, L., Curtis, A.J., Breslin, M. and Nelson, M., 2020. The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis. Drugs & Aging, doi:10.1007/s40266-019-00736-y.
  84. Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T., Mulrow, C.D., Shamseer, L. and Moher, D., 2020. Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines. Journal of Clinical Epidemiology, 118:60-68.
  85. Lewis, J.S., Cook, C.E., Hoffmann, T.C. and O'Sullivan, P., 2020. The Elephant in the Room: Too Much Medicine in Musculoskeletal Practice. Journal of orthopaedic & sports physical therapy, 50(1), 1-4.
  86. Kahan, B.C., Tsui, M., Jairath, V., Scott, A.M., Altman, D.G., Beller, E. and Elbourne, D., 2019. Reporting of randomised factorial trials was frequently inadequate. Journal of Clinical Epidemiology, 117: 52-59.
  87. Cleo, G., Beller, E., Glasziou, P., Isenring, E. and Thomas, R., 2020. Efficacy of habit-based weight loss interventions: a systematic review and meta-analysis. J Behav Med, 43(4):519–532.
  88. The HALT-IT Trial Collaborators., 2020. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. The Lancet, 395(10241), pp.1927-1936.
  89. Global Tuberculosis Network, 2020. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. International Journal of Infectious Diseases, 92, pp.S15-S25.
  90. Pediatric TB Contact Studies Consortium, 2020. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet, 395(10228): pp. 973-984.

Other (Commentary, Editorials, Letters, Viewpoint etc)

  1. Pilla, B., Scott, A.M. and Jordan, Z., 2020. If not now, when? Time to focus on “evidence to impact”. JBI Evidence Synthesis, 18(10), pp.2104-2105.
  2. Tikkinen, K.A., Malekzadeh, R., Schlegel, M., Rutanen, J. and Glasziou, P., 2020. COVID-19 clinical trials: learning from exceptions in the research chaos. Nature Medicine, pp.1-2.
  3. Stehlik P., Henry D. and Glasziou P., 2020. Specialist college training: a potential source of research wastage. BMJ Opinion. Retrieved from https://blogs.bmj.com/bmj/2020/07/14/specialist-college-training-a-potential-source-of-research-wastage/
  4. Sotgiu, G. and Dobler, C.C., 2020. Social stigma in the time of Coronavirus. Eur Respir J, 45(2): 02461
  5. Dobler, C.C., 2020. Poor quality research and clinical practice during COVID-19. Breathe, 16(2): 200112.
  6. Moynihan, R., Johansson, M., Maybee, A., Lang, E. and Légaré, F., 2020. Covid-19: an opportunity to reduce unnecessary healthcare, BMJ, 370:m2752.
  7. Clark, J., Scott, A.M. and Glasziou, P., 2020. Not All Systematic Reviews Can Be Completed in 2 Weeks-But Many Can Be (And Should Be). Journal of clinical epidemiology, pp.S0895-4356.
  8. Moynihan, R., Macdonald, H., Bero, L. and Godlee, F., 2020. Commercial influence and covid-19, BMJ, 369:m2456.
  9. Raftery, C., Lewis, E.T., Cardona, M. 2020. The crucial role of nurses and social workers in initiating end-of-life communication to reduce overtreatment in the midst of the COVID-19 pandemic. Gerontology
  10. Glasziou, P.P., Sanders, S. and Hoffmann, T., 2020. Waste in covid-19 research. BMJ, 369:m1847.
  11. O’Connor, A.M., Glasziou, P., Taylor, M., Thomas, J., Spijker, R. and Wolfe, M.S., 2020. A focus on cross-purpose tools, automated recognition of study design in multiple disciplines, and evaluation of automation tools: a summary of significant discussions at the fourth meeting of the International Collaboration for Automation of Systematic Reviews (ICASR). Systematic Reviews, 9(1), pp.1-6.
  12. Glasziou, P. and Doust, J., 2020. In patients with hypertension, taking all BP-lowering drugs at bedtime vs in the morning reduced CV events. Comment. Annals of Internal Medicine, 172(6), pp.JC29-JC29.
  13. Elessi, K., Albarqouni, L., Glasziou, P. and Chalmers, I., 2020. Training in critical appraisal skills: Authors' reply. The Lancet, 395(10229), p.e60.
  14. Nakagawa, S., Dunn, A.G., Lagisz, M., Bannach-Brown, A., Grames, E.M., Sánchez-Tójar, A., O’Dea, R.E., Noble, D.W., Westgate, M.J., Arnold, P.A. and Barrow, S., 2020. A new ecosystem for evidence synthesis. Nature Ecology & Evolution, pp.1-4.
  15. Dobler, C.C., 2020. Screening and surveillance in respiratory medicine. Breathe, 16(1): 200038.
  16. Moynihan, R., 2020. Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company. Journal of Bioethical Inquiry, pp.1-3.
  17. Cardona, M., Wee, I.J.Y., Lewis, E.T., Hunt, J., Greenaway, S., Hillman, K., Ní Chróinín, D. 2020. Strategies for improving end-of-life discussions. Community Care Review, Australian Ageing Agenda, Jan-Feb 2020, p. 16-17.
  18. Zadro, J.R., Décary, S., O'Keeffe, M., Michaleff, Z.A. and Traeger, A.C., 2020. Overcoming Overuse: Improving Musculoskeletal Health Care, 50(3): 113-115.
  19. Bell, K.J., Semsarian, C. and Doust, J., 2020. Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia. Annals of Internal Medicine.
  20. Doust, J.A., Bell, K.J. and Glasziou, P.P., 2020. Potential Consequences of Changing Disease Classifications. JAMA, pp.921-922.